Feed / WAT

Waters Corporation

WAT

Healthcare · 410.73 +1.4% today

Partial group confirmationMarket checked 21 Aug, 15:55 GMT-4

Jodie situation report

Waters Corporation's move is being confirmed by its market group.

WAT accounts for 10.9% of the group's measured movement across 9.2 effective names. raw member direction is mixed; 10 of 10 SPY-adjusted paths align to the upside. Capital-flow agreement is 39%, so confirmation is not yet clean. No verified headline preceded the measured group move.

MOVE ANATOMY

Is this move genuinely shared?

SPY-adjusted 5m paths
Role in the moveAligned contributor#4 of 10 by movement share
Group movement share10.9%Absolute path energy—not portfolio weight
Relative path+1.21%aligned
Effective breadth9.2 / 10broad
Relative alignment10/10upside path · 0 counter-moving
Capital-flow agreement39%not yet clean
SEQUENCE READ

SHC, RGEN, MTD moved materially before WAT. WAT crossed its material path threshold at 11:05 ET, 20 minutes after the first measured mover. DHR, A followed.

EVIDENCE COVERAGE

5 of 10 members in Healthcare Diagnostics are active. 0 of 8 disclosed connections are confirming.

What would change this read
  • At least 7 of 10 durable members become active together.
  • Capital-flow agreement rises above 55%.
  • A filing-linked outsider such as BRKR begins moving with the group.

Invalidation: The live read weakens if participation falls to 3 of 10 members or fewer.

Watch this read

Who this business touches

The relationships behind WAT

Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.

Depends on

AAgilent Technologies, Inc.competitorFeb 23, 2026

In the markets served by Waters, the Company’s principal competitors include: Agilent Technologies, Inc., Shimadzu Corporation, Bruker Corporation, Danaher Corporation and Thermo Fisher Scientific Inc.

BDXBecton, Dickinson and CompanyinvesteeMay 12, 2026

Acquisition of BD Biosciences & Diagnostic Solutions Businesses On February 9, 2026 (the “Closing Date”), the Company completed the acquisition (the “BDS Business Acquisition”) of the Biosciences and Diagnostic Solutions business (the “BDS Business”) of Becto…

Depended on by

AAgilent Technologies, Inc.competitorDec 22, 2025

Our principal competitors in the Life Sciences and Diagnostics Markets arena include: AB Sciex., a division of Danaher Corporation, Avecia, a division of Nitto Denko, Bruker, Inc., Leica Biosystems, Inc., a division of Danaher Corporation, Roche Ventana Medic…

Filing peers

Companies whose filings use similar operating language.

Open the three relationships above to see Jodie’s filing proof. Pro unlocks 11 more links, every receipt, and alerts when connected names begin moving. Unlock the full network →

What is moving around it

Live connections

WAT is currently a Early Follower in the organic co-movement group Healthcare Diagnostics. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 3 filing-linked names are in the relationship map; none is currently confirmed as moving with the group.